Adjunct faculty typically have an academic or research appointment at another institution and contribute or collaborate with one or more School of Medicine faculty members or programs.
Adjunct rank detailsSyed Bilgrami, MBBS
Adjunct Assistant ProfessorAbout
Copy Link
Titles
Adjunct Assistant Professor
Biography
Dr. Bilgrami received his Medical Degree from Dow Medical College in 1984. After Residency Training in Internal Medicine in Karachi, at Wayne State University Hospital, and at the University of Connecticut Health Center, he completed his Fellowship Training in Medical Oncology and Hematology at the University of Connecticut Health Center. He also did a special Fellowship in Bone Marrow Transplantation at the Fred Hutchinson Cancer Center in Seattle, Washington. Dr. Bilgrami joined the Faculty of the University of Connecticut Health Center in 1994 as an Assistant Professor of Medicine. He became the Deputy Director of the University of Connecticut Health Center Bone Marrow Transplant Program and was appointed Associate Professor of Medicine in 2000. Dr. Bilgrami has published extensively in the field of Clinical Bone Marrow Transplantation and is regarded as an expert in Blood Cancers.
Appointments
Medical Oncology and Hematology
Assistant Professor AdjunctPrimary
Other Departments & Organizations
- Internal Medicine
- Medical Oncology and Hematology
- Yale Cancer Center
Education & Training
- Fellowship
- University of Connecticut School of Medicine (1993)
- Fellowship
- University of Connecticut School of Medicine (1992)
- Resident
- Wayne State University School of Medicine (1989)
- MBBS
- Dow Medical College (1984)
Research
Copy Link
Research at a Glance
Yale Co-Authors
Mary Ellen Dwyer
Publications
2024
Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma, Version 2.2024, NCCN Clinical Practice Guidelines in Oncology
Wierda W, Brown J, Abramson J, Awan F, Bilgrami S, Bociek G, Brander D, Cortese M, Cripe L, Davis R, Eradat H, Fakhri B, Fletcher C, Gaballa S, Hamid M, Hill B, Kaesberg P, Kahl B, Kamdar M, Kipps T, Ma S, Mosse C, Nakhoda S, Parikh S, Schorr A, Schuster S, Seshadri M, Siddiqi T, Stephens D, Thompson M, Ujjani C, Valdez R, Wagner-Johnston N, Woyach J, Sundar H, Dwyer M. Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma, Version 2.2024, NCCN Clinical Practice Guidelines in Oncology. Journal Of The National Comprehensive Cancer Network 2024, 22: 175-204. PMID: 38626800, DOI: 10.6004/jnccn.2024.0018.Peer-Reviewed Original ResearchCitationsAltmetricMeSH Keywords and ConceptsConceptsSmall lymphocytic lymphomaChronic lymphocytic leukemiaPredictor of improved survivalUndetectable minimal residual diseaseImmunoglobulin heavy chain variable region mutational statusMinimal residual diseaseManagement of patientsSelection of treatmentRelapsed/refractory CLL/SLLLymphocytic lymphomaResidual diseaseCombination regimensTP53 mutationsMutation statusPerformance statusLymphocytic leukemiaNCCN guidelinesPatient agePrognostic implicationsToxicity profileDisease stageComorbid conditionsPatientsCLL/SLLCytogenetic variability
Get In Touch
Copy Link